BRIEF-Quest Diagnostics to acquire Cape Cod Healthcare outreach laboratory business
* Quest Diagnostics announces intent to acquire Cape Cod Healthcare outreach laboratory business in Massachusetts
March 16 Shire Plc
* Shire receives european approval for label extension of Cinryze(C1 inhibitor) to prevent and treat hereditary angioedema (HAE) attacks in paediatric patients with hae
* Cinryze is also now approved for treatment and pre-procedure prevention of Angioedema attacks in children (ages 2 years and above) with HAE Source text for Eikon: Further company coverage:
June 27 Linde AG's Lincare unit has agreed to pay $20 million to resolve a whistleblower lawsuit accusing the company of fraudulently billing the U.S. government for oxygen and respiratory care equipment.
* Virus transmitted via "phishing" emails (Updates throughout)